Pharmacologic treatments for covid-19 patients

Favipiravir Early vs Favipiravir Late

This comparison will not be updated. Last search date 14 Dec, 2022.


Hospitalized patients

Forest plots
(last update: 2021-06-10)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=92

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
jRCTs041190120
Doi Y, Antimicrob Agents Ch, 2020
Full text
Commentary
Mixed

Favipiravir

Favipiravir

RCT Patients with confirmed COVID-19 (asymptomatic-mild-moderate) admitted to multiple centers in Japan N=89
Some concerns
Details

Full description